Saturday 17 October 2026
Export CRKN’s income statement to Excel — free account
Crown Electrokinetics Corp.
CRKN Basic Materials Specialty Chemicals
Crown Electrokinetics Corp.’s revenue for fiscal 2024 (year ended December 2024) was $19.7 million, up 12,776.5% from fiscal 2023. In the quarter to March 2025, revenue grew 306.5%, EPS grew 99.8% and free cash flow fell 362.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.00
0.01
−100.00%
Follow CRKN
| Older periods | Jun '24 | Sep '24 | Dec '24 | Mar '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(416.46%) | (317.74%) | (241.21%) | (195.09%) | |
| (197.36%) | (204.75%) | (145.89%) | (142.30%) | ||
ROIC |
(232.29%) | (186.21%) | (163.47%) | (134.95%) | |
Return on Tangible Assets |
(431.17%) | (390.70%) | (155.75%) | (108.10%) | |
Average Days of Receivables |
223.97 | 132.02 | 99.23 | 82.75 | |
Free Cash Flow per Share |
(1,550.85) | (619.33) | (0.41) | (20.48) | |
Free Cash Flow |
(18.14) | (19.32) | (24.33) | (34.26) | |
Capital Expenditures |
(1.52) | (3.21) | (6.14) | (7.74) | |
| Other line items | |||||
Cash ROIC |
(138.85%) | (145.07%) | (66.42%) | (58.12%) | |
Accounts Receivable Turnover |
3.24 | 5.29 | 7.24 | 7.62 | |
Accounts Payable Turnover |
3.41 | 4.28 | 5.89 | 7.71 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
117.34 | 119.50 | 97.21 | 57.45 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
69.27% | 29.80% | 17.09% | 16.92% | |
Selling, General and Administrative Expense of Revenue |
243.95% | 125.46% | 101.75% | 118.97% | |
Share Based Compensation of Revenue |
51.73% | 35.99% | 26.65% | 32.54% | |
Interest Coverage |
(3.21) | (6.17) | (24.27) | 473.77 | |
Operating CF/Net income |
0.60 | 0.53 | 0.56 | 0.71 | |
Depreciation/Fixed assets |
2.29 | 1.00 | 0.38 | 0.27 | |
Capex/Depreciation |
(0.22) | (0.60) | (1.92) | (3.04) | |
Revenue per Share |
466.75 | 431.44 | 0.33 | 13.03 | |
Operating CF per Share |
(1,420.77) | (516.38) | (0.31) | (15.85) | |
Capex per Share |
(130.09) | (102.95) | (0.10) | (4.63) | |
Capex to Sales |
0.28 | 0.24 | 0.31 | 0.36 |
Columns are period end dates